two hundred and fifty-two patients with advanced stages of favorable non-hodgkin 's lymphoma ( nhl ) subtypes ( nodular histiocytic ( nh ) , and diffuse well-differentiated lymphocytic ( dlwd ) ) were analyzed for response and survival to moderate ( cyclophosphamide-prednisone ( cp ) ) vs. intensive ( bcvp or copp ) chemotherapy regimens .
C1706733
advanced
C0024264
lymphocytic